These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 16670640

  • 41. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB, Xue YX, Liu YH, Wang YB.
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [Abstract] [Full Text] [Related]

  • 42. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, Kim KA, Liu Y, Levy MD, Berg DJ, Abo A, Funk WD.
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [Abstract] [Full Text] [Related]

  • 43. Insulin-like growth factor binding protein-3 inhibits colitis-induced carcinogenesis.
    Belizon A, Balik E, Kirman I, Remotti H, Ciau N, Jain S, Whelan RL.
    Dis Colon Rectum; 2007 Sep; 50(9):1377-83. PubMed ID: 17668267
    [Abstract] [Full Text] [Related]

  • 44. Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10.
    Leung G, Wang A, Fernando M, Phan VC, McKay DM.
    Am J Physiol Gastrointest Liver Physiol; 2013 May 01; 304(9):G781-92. PubMed ID: 23494123
    [Abstract] [Full Text] [Related]

  • 45. Serotonin has a key role in pathogenesis of experimental colitis.
    Ghia JE, Li N, Wang H, Collins M, Deng Y, El-Sharkawy RT, Côté F, Mallet J, Khan WI.
    Gastroenterology; 2009 Nov 01; 137(5):1649-60. PubMed ID: 19706294
    [Abstract] [Full Text] [Related]

  • 46. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
    Clark JA, Doelle SM, Halpern MD, Saunders TA, Holubec H, Dvorak K, Boitano SA, Dvorak B.
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov 01; 291(5):G938-49. PubMed ID: 16798726
    [Abstract] [Full Text] [Related]

  • 47. Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis.
    Esposito E, Mazzon E, Riccardi L, Caminiti R, Meli R, Cuzzocrea S.
    J Pineal Res; 2008 Sep 01; 45(2):166-73. PubMed ID: 18429971
    [Abstract] [Full Text] [Related]

  • 48. Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.
    Cuzzocrea S, Rossi A, Serraino I, Di Paola R, Dugo L, Genovese T, Britti D, Sciarra G, De Sarro A, Caputi AP, Sautebin L.
    Intensive Care Med; 2004 Oct 01; 30(10):1935-43. PubMed ID: 15241586
    [Abstract] [Full Text] [Related]

  • 49. Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, ameliorates intestinal damage in rat models of colitis and shock.
    Di Paola R, Mazzon E, Xu W, Genovese T, Ferrraris D, Muià C, Crisafulli C, Zhang J, Cuzzocrea S.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):163-71. PubMed ID: 16310767
    [Abstract] [Full Text] [Related]

  • 50. Vagus nerve integrity and experimental colitis.
    Ghia JE, Blennerhassett P, Collins SM.
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep 19; 293(3):G560-7. PubMed ID: 17585014
    [Abstract] [Full Text] [Related]

  • 51. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B.
    Curr Eye Res; 2006 Dec 19; 31(12):1033-45. PubMed ID: 17169842
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease.
    Chen P, Bakke D, Kolodziej L, Lodolce J, Weber CR, Boone DL, Toback FG.
    Inflamm Bowel Dis; 2015 Oct 19; 21(10):2393-2402. PubMed ID: 26197453
    [Abstract] [Full Text] [Related]

  • 55. TNF-alpha is crucial for the development of mast cell-dependent colitis in mice.
    Rijnierse A, Koster AS, Nijkamp FP, Kraneveld AD.
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov 19; 291(5):G969-76. PubMed ID: 16798721
    [Abstract] [Full Text] [Related]

  • 56. Hepatocyte tight-junctional permeability is increased in rat experimental colitis.
    Lora L, Mazzon E, Martines D, Fries W, Muraca M, Martin A, d'Odorico A, Naccarato R, Citi S.
    Gastroenterology; 1997 Oct 19; 113(4):1347-54. PubMed ID: 9322530
    [Abstract] [Full Text] [Related]

  • 57. Interleukin-1beta-induced disruption of barrier function in cultured human corneal epithelial cells.
    Kimura K, Teranishi S, Nishida T.
    Invest Ophthalmol Vis Sci; 2009 Feb 19; 50(2):597-603. PubMed ID: 19171646
    [Abstract] [Full Text] [Related]

  • 58. Intestinal deletion of Claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice.
    Tanaka H, Takechi M, Kiyonari H, Shioi G, Tamura A, Tsukita S.
    Gut; 2015 Oct 19; 64(10):1529-38. PubMed ID: 25691495
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M.
    Gut; 2009 Feb 19; 58(2):196-201. PubMed ID: 18824556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.